How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?
Abstract Several randomized controlled trials of anti-estrogens, such as tamoxifen and aromatase inhibitors, have demonstrated up to a 50–65% decrease in breast cancerincidence among high-risk women. Approximately 15% of women, age 35–79 years, in the U.S. meet criteria for breast cancer preventive...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2017
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/9e9b0c4255f248ec9c7a12bc8d55c04e |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|